Physician profile
Alexis Light
NPI 1144648502
$2,980.54
in general payments reported to CMS, 2019-2025
33 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $183 · 2021: $443 · 2022: $834 · 2023: $318 · 2024: $590 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,237.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $374.74 | 2019-2022 | |
| Astellas Pharma US INC | $258.04 | 2022-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $231.69 | 2019-2025 | |
| Organon LLC | $203.90 | 2021-2025 | Nexplanon |
| Pfizer INC. | $181.19 | 2023-2025 | |
| Therapeuticsmd, INC. | $169.38 | 2019-2022 | |
| Coopersurgical, INC. | $162.42 | 2022-2025 | Paragard T 380a, Summit Doppler, Paragard T 380a |
| Caldera Medical, INC | $139.21 | 2024 | Desara |
| Myovant Sciences INC. | $132.23 | 2022 | |
| Daiichi Sankyo INC. | $130.82 | 2019-2020 | |
| Exeltis, USA INC. | $126.89 | 2020-2025 | Slynd |
| Sumitomo Pharma America, INC. | $125.76 | 2023-2025 | Myfembree |
| Aspira Women'S Health INC | $121.41 | 2020-2022 | |
| Optumhealth Care Solutions, LLC | $63.31 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Dysis Medical, INC. | $57.47 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $56.51 | 2023-2024 | Accrufer |
| Hologic Sales and Service, LLC | $52.02 | 2020-2021 | |
| Gynesonics, INC. | $46.94 | 2021 | |
| Ethicon US, LLC | $42.92 | 2023 | Enseal, Stratafix, Ethicon |
| Duchesnay USA Incorporated | $42.11 | 2019 | |
| Millicent US INC | $38.22 | 2025 | Femring, Femlyv, Intrarosa |
| Mayne Pharma Commercial LLC | $31.65 | 2022-2023 | |
| Avion Pharmaceuticals | $28.89 | 2021-2022 | |
| Dexcom, INC. | $22.95 | 2025 | Dexcom G6 Transmitter |
| Renovia INC | $20.86 | 2021 | |
| Medtronic, INC. | $19.41 | 2024 | V-Loc 180 |
| Seqirus USA INC | $18.91 | 2025 | Flucelvax |
| Merck Sharp & Dohme LLC | $17.71 | 2019 | |
| Mission Pharmacal Company | $15.00 | 2019 | |
| Evofem Biosciences, INC. | $14.34 | 2021 | |
| Mylan Pharmaceuticals INC. | $13.82 | 2019 | |
| Minerva Surgical, INC | $12.32 | 2022 | |
| Vapotherm INC | $7.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Light listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.